Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “chronic myeloid leukemia”
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT07269470. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality
ClinicalTrials.gov study NCT03746054. IPD Sharing: NO. Countries: 1. Publications: 0.
Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib
ClinicalTrials.gov study NCT02398825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting
ClinicalTrials.gov study NCT04089839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01805843. IPD Sharing: Not stated. Countries: 1. Publications: 0.
G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission
ClinicalTrials.gov study NCT00233961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03817398. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01227135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00011934. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
ClinicalTrials.gov study NCT01761890. IPD Sharing: NO. Countries: 1. Publications: 0.
6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00003997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients
ClinicalTrials.gov study NCT02164903. IPD Sharing: NO. Countries: 4. Publications: 0.
Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04709731. IPD Sharing: NO. Countries: 1. Publications: 0.
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT02734823. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06401603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
ClinicalTrials.gov study NCT01215487. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia
ClinicalTrials.gov study NCT00004181. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
ClinicalTrials.gov study NCT05734053. IPD Sharing: NO. Countries: 1. Publications: 0.
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuatio
ClinicalTrials.gov study NCT04838041. IPD Sharing: NO. Countries: 1. Publications: 0.
Metoclopramide treatment blocks CD93-signaling mediated self-renewal of chronic myeloid leukemia stem cells
GEO Series GSE149358. Mus musculus. 16 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.